To include your compound in the COVID-19 Resource Center, submit it here.

NICE backs Simponi

The U.K.'s NICE issued a final appraisal determination recommending the use of Simponi golimumab from Merck &

Read the full 175 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE